Islet transplantation for insulin-dependent diabetes mellitus (type 1 diabetes mellitus) by the Edmonton protocol is widely used, but this therapeutic approach has a major limitation in that islets from two to four cadaveric pancreas are required to achieve insulin independence in one diabetic recipient. This evidence concerns the gene INS and diabetes mellitus.